The Claim
The median antibody titer against the immunodominant HERV-K Env peptide GKTCPKEIPKGSKNT is significantly higher in patients with systemic lupus erythematosus (SLE) than in healthy controls and patients with other rheumatic diseases, with a p-value of less than 0.003.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
People with systemic lupus erythematosus (SLE) have higher levels of antibodies targeting a specific viral-like protein fragment compared to healthy individuals and people with other autoimmune diseases.
See the scientific wording
The median antibody titer against the immunodominant HERV-K Env peptide GKTCPKEIPKGSKNT is significantly higher in patients with systemic lupus erythematosus (SLE) compared to healthy controls and patients with other rheumatic diseases, with a p-value of less than 0.003.
What the research says
1 studyScientists found that people with lupus have much higher levels of certain antibodies that stick to a specific part of an ancient virus in our DNA, compared to healthy people or those with other autoimmune diseases. This supports the idea that lupus is linked to a stronger immune reaction to this particular viral fragment.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.